美國微創手術市場：市場規模、佔有率和趨勢分析（按外科專科、手術類型、最終用途和支付方類型分類），細分市場預測（2025-2033 年）

市場規模與趨勢：

預計到 2024 年，美國微創手術 (MIS) 市場規模將達到 1,658.9 億美元，到 2033 年將達到 3,182.7 億美元，2025 年至 2033 年的複合年成長率為 7.66%。

市場成長的主要驅動力是肥胖、心血管疾病和癌症等慢性疾病的日益普遍。這些疾病通常需要手術治療，但能夠縮短恢復時間、減少併發症的治療方法尤其重要。此外，機器人手術、高畫質影像、腹腔鏡器械和導航系統等外科技術的進步，使外科醫生能夠更精準地完成複雜的手術，同時最大限度地減少病患創傷。患者對微創手術益處的認知不斷提高，也進一步推動了對這類手術的需求。

手術機器人技術的進步徹底革新了微創手術（MIS），提高了外科醫生的操作靈活性，改善了術野可視化（通常藉助3D成像），並促進了透過微小切口進行更精準的操作。這些優勢降低了某些複雜手術的門檻，使得原本可能需要開放性手術的手術能夠以微創的方式進行。根據美國醫院協會（AHA）統計，截至2024年，達文西機器人手術系統在全球已完成約268萬例手術，其中263萬例發生在美國。因此，像達文西機器人這樣的植入正在幫助擴大微創手術在泌尿系統、婦科和一般外科等專科領域的應用範圍。

此外，醫院數據也強力地支持了這一趨勢：已實施機器人輔助手術（RAS）的中心往往微創手術（MIS）率更高，這並非簡單地用一種手術替代另一種，而是擴大了微創手術在病患小組中的應用範圍。這表明，RAS並非用機器人手術取代腹腔鏡手術，而是將微創手術的益處惠及更多原本可能需要接受開放性手術的病人。

內視鏡檢查在美國醫療保健領域至關重要，尤其是在胃腸道疾病的診斷和治療方面。根據多方資訊來源，2023年美國共進行了約213萬例內視鏡檢查。如此高的檢查量反映了內視鏡檢查與微創診斷和治療策略的緊密聯繫。大腸鏡檢查仍然是癌症預防計畫的重要組成部分，每年有超過1500萬人接受此項檢查。

目錄

第1章 分析方法和範圍

第2章執行摘要

第3章美國微創手術（MIS）市場：促進因素、趨勢與範圍

• 市場聯動展望
  • 母市場展望
  • 相關/附隨市場展望
• 市場動態
  • 市場促進因素分析
  • 市場限制因素分析
• 微創手術 (MIS) 市場：分析工具
  • 產業分析：波特五力分析
  • PESTEL 分析
• 微創手術（MIS）市場：手術數量
• 微創手術（MIS）市場：平均手術費用

第4章美國微創手術（MIS）市場：外科專科的估計與趨勢分析

• 細分儀表板
• 微創手術（MIS）市場：依外科專科分類的差異分析
• 微創手術（MIS）市場：依外科專科分類的展望
• 市場規模預測及趨勢分析（2021-2033）
• 一般外科
• 胃腸外科手術
• 泌尿系統手術
• 心胸外科
• 整形外科/脊椎手術
• 神經外科
• 大腸直腸手術
• 減重手術
• 血管/血管內手術
• 整形外科/重組外科

第5章美國微創手術（MIS）市場：依方法分類的估計與趨勢分析

• 細分儀表板
• 微創手術 (MIS) 市場：按方法分類的差異分析
• 微創手術（MIS）市場：按技術分類的展望
• 市場規模預測及趨勢分析（2021-2033）
• 腹腔鏡手術
• 胸腔鏡手術/VATS
• 機器人輔助手術
• 內視鏡手術
• 導管介入/介入治療
• 其他

第6章美國微創手術（MIS）市場：按支付方類型分類的估計與趨勢分析

• 細分儀表板
• 微創手術 (MIS) 市場：按支付方類型分類的銷售分析
• 微創手術 (MIS) 市場：按支付方類型分類的展望
• 市場規模預測及趨勢分析（2021-2033）
• 私人醫療保險
• 聯邦醫療保險
• 醫療補助
• 自費
• 其他付款方

第7章美國微創手術（MIS）市場：依最終用途分類的估計與趨勢分析

• 細分儀表板
• 微創手術 (MIS) 市場：按最終用途分類的差異分析
• 微創手術 (MIS) 市場：按最終用途分類的展望
• 市場規模預測及趨勢分析（2021-2033）
• 醫院
• 門診手術中心（ASC）
• 專科診所
• 其他

第8章 競爭情勢

• 市場參與企業分類
• 主要企業簡介
  • Medtronic plc
  • Intuitive Surgical
  • CMR Surgical
  • Smith & Nephew plc
  • Renishaw
  • Monteris Medical
  • PROCEPT BioRobotics
  • EndoQuest Robotics
  • Moon Surgical
  • Asensus Surgical US, Inc.
  • Olympus Corporation

Market Size & Trends:

The U.S. minimally invasive surgery (MIS) market size was valued at USD 165.89 billion in 2024 and is expected to reach USD 318.27 billion by 2033, growing at a CAGR of 7.66% from 2025 to 2033. A key factor driving market expansion is the rising prevalence of chronic conditions such as obesity, cardiovascular diseases, and cancer. These conditions often require surgery but benefit from approaches that shorten recovery times and lower complications. Additionally, ongoing innovations in surgical technology-like robotics, high-definition imaging, laparoscopic instruments, and navigation systems-enable surgeons to perform complex procedures more accurately while minimizing patient trauma. Increasing patient awareness about the advantages of minimally invasive techniques has further propelled the demand for these procedures.

Advances in surgical robotics have revolutionized minimally invasive surgery (MIS) by enhancing surgeons' dexterity, improving visualization (often with 3D imaging), and facilitating more precise movements through small incisions. These benefits lower the barrier of complexity for certain procedures, enabling operations that may have required open surgery to now be performed less invasively. According to the American Hospital Association (AHA), as of 2024, the da Vinci robotic surgical system facilitated around 2.68 million procedures globally, and 2.63 million were carried out in the U.S. As a result, implants such as the da Vinci robot have contributed to an expanded scope of MIS across specialties, including urology, gynecology, general surgery, and more.

Furthermore, evidence from hospital data shows this trend in action. Facilities that introduce robotic-assisted surgery (RAS) capabilities tend to increase their rate of MIS, not merely replacing one minimally invasive method with another but expanding overall usage of less invasive approaches across patient groups. This indicates that RAS does not replace laparoscopic methods for robotic ones; it enables more patients who previously might have undergone open surgery to access the benefits of MIS.

Endoscopic procedures are critical in U.S. healthcare, especially for gastrointestinal diagnosis and treatment. According to several sources, approximately 2.13 million endoscopies were performed in the U.S. in 2023. These high procedure volumes reflect how deeply endoscopy intertwines minimally invasive diagnostic and therapeutic strategies. Colonoscopy remains the cornerstone of cancer prevention programs, with more than 15 million individuals undergoing the procedure annually.

U.S. Minimally Invasive Surgery Market Report Segmentation

This report forecasts revenue growth at the country level and analyzes the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. minimally invasive surgery (MIS) market report based on surgical specialty, method, payer type, and end-use:

• Surgical Specialty Outlook (Revenue, USD Million, 2021 - 2033)
• General Surgery
• Gastrointestinal Surgery
• Gynecological Surgery
• Urological Surgery
• Cardiothoracic Surgery
• Orthopedic & Spine Surgery
• Neurosurgery
• Colorectal Surgery
• Bariatric Surgery
• Vascular & Endoscopic Surgery
• Plastic & Reconstructive Surgery
• Method Outlook (Revenue, USD Million, 2021 - 2033)
• Laparoscopic Surgery
• Thoracoscopic Surgery/VATS
• Robotic-assisted Surgery
• Endoscopic Surgery
• Catheter-based/ Interventional Procedures
• Others
• Payer Type Outlook (Revenue, USD Million, 2021 - 2033)
• Private Health Insurance
• Medicare
• Medicaid
• Out-of-Pocket/ Self-pay
• Other Payers
• End-use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals
  • Public Hospitals
  • Private Hospitals
  • Private Hospitals-for profit
  • Private Hospitals-non-profit
• Ambulatory Surgical Centers
• Specialty Clinics
• Others

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Surgical Specialty
  • 1.2.2. Method
  • 1.2.3. Payer Type
  • 1.2.4. End-use
  • 1.2.5. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Surgical Specialty outlook
  • 2.2.2. Method outlook
  • 2.2.3. Payer Type outlook
  • 2.2.4. End-use outlook
• 2.3. Competitive Insights

Chapter 3. U.S. Minimally Invasive Surgery (MIS) Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Rising surgical volumes
    • 3.2.1.2. Technological advancements in surgical robotics & imaging
    • 3.2.1.3. Growing shift toward outpatient care
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High capital and procedure costs
    • 3.2.2.2. Complex training requirements
• 3.3. Minimally Invasive Surgery (MIS) Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape
• 3.4. Minimally Invasive Surgery (MIS) Market: Number of Procedures
• 3.5. Minimally Invasive Surgery (MIS) Market: Average Procedure Pricing

Chapter 4. U.S. Minimally Invasive Surgery (MIS) Market: Surgical Specialty Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Minimally Invasive Surgery (MIS) Market: Surgical Specialty Movement Analysis
• 4.3. Minimally Invasive Surgery (MIS) Market by Surgical Specialty Outlook (USD Million)
• 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 4.5. General Surgery
  • 4.5.1. General Surgery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.6. Gastrointestinal Surgery
  • 4.6.1. Gastrointestinal Surgery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.7. Urological Surgery
  • 4.7.1. Urological Surgery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.8. Cardiothoracic Surgery
  • 4.8.1. Cardiothoracic Surgery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.9. Orthopedic & Spine Surgery
  • 4.9.1. Orthopedic & Spine Surgery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.10. Neurosurgery
  • 4.10.1. Neurosurgery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.11. Colorectal Surgery
  • 4.11.1. Colorectal Surgery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.12. Bariatric Surgery
  • 4.12.1. Bariatric Surgery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.13. Vascular & Endovascular Surgery
  • 4.13.1. Vascular & Endovascular Surgery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.14. Plastic & Reconstructive Surgery
  • 4.14.1. Plastic & Reconstructive Surgery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Minimally Invasive Surgery (MIS) Market: Method Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Minimally Invasive Surgery (MIS) Market: Method Movement Analysis
• 5.3. Minimally Invasive Surgery (MIS) Market by Method Outlook (USD Million)
• 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 5.5. Laparoscopic Surgery
  • 5.5.1. Laparoscopic Surgery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.6. Thoracoscopic Surgery/VATS
  • 5.6.1. Thoracoscopic Surgery/VATS Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.7. Robotic-assisted Surgery
  • 5.7.1. Robotic-assisted Surgery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.8. Endoscopic Surgery
  • 5.8.1. Endoscopic Surgery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.9. Catheter-based/Interventional Procedures
  • 5.9.1. Catheter-based/Interventional Procedures Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.10. Others
  • 5.10.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. U.S. Minimally Invasive Surgery (MIS) Market: Payer Type Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Minimally Invasive Surgery (MIS) Market: Payer Type Movement Analysis
• 6.3. Minimally Invasive Surgery (MIS) Market by Payer Type Outlook (USD Million)
• 6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 6.5. Private Health Insurance
  • 6.5.1. Private Health Insurance Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.6. Medicare
  • 6.6.1. Medicare Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.7. Medicaid
  • 6.7.1. Medicaid Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.8. Out-of-Pocket/Self-pay
  • 6.8.1. Out-of-Pocket/Self-pay Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.9. Other Payers
  • 6.9.1. Other Payers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. U.S. Minimally Invasive Surgery (MIS) Market: End-use Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Minimally Invasive Surgery (MIS) Market: End-use Movement Analysis
• 7.3. Minimally Invasive Surgery (MIS) Market by End-use Outlook (USD Million)
• 7.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 7.5. Hospitals
  • 7.5.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.1.1. Public hospitals
    • 7.5.1.2. Private hospitals
      • 7.5.1.2.1. Private hospitals-for profit
      • 7.5.1.2.2. Private hospitals-non-profit
• 7.6. Ambulatory Surgical Centers (ASCs)
  • 7.6.1. Ambulatory Surgical Centers (ASCs) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.7. Specialty Clinics
  • 7.7.1. Specialty Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.8. Others
  • 7.8.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Market Participant Categorization
• 8.2. Key Company Profiles
  • 8.2.1. Medtronic plc
    • 8.2.1.1. Company overview
    • 8.2.1.2. Financial performance
    • 8.2.1.3. Product benchmarking
    • 8.2.1.4. Strategic initiatives
  • 8.2.2. Intuitive Surgical
    • 8.2.2.1. Company overview
    • 8.2.2.2. Financial performance
    • 8.2.2.3. Product benchmarking
    • 8.2.2.4. Strategic initiatives
  • 8.2.3. CMR Surgical
    • 8.2.3.1. Company overview
    • 8.2.3.2. Financial performance
    • 8.2.3.3. Product benchmarking
    • 8.2.3.4. Strategic initiatives
  • 8.2.4. Smith & Nephew plc
    • 8.2.4.1. Company overview
    • 8.2.4.2. Financial performance
    • 8.2.4.3. Product benchmarking
    • 8.2.4.4. Strategic initiatives
  • 8.2.5. Renishaw
    • 8.2.5.1. Company overview
    • 8.2.5.2. Financial performance
    • 8.2.5.3. Product benchmarking
    • 8.2.5.4. Strategic initiatives
  • 8.2.6. Monteris Medical
    • 8.2.6.1. Company overview
    • 8.2.6.2. Financial performance
    • 8.2.6.3. Product benchmarking
    • 8.2.6.4. Strategic initiatives
  • 8.2.7. PROCEPT BioRobotics
    • 8.2.7.1. Company overview
    • 8.2.7.2. Financial performance
    • 8.2.7.3. Product benchmarking
    • 8.2.7.4. Strategic initiatives
  • 8.2.8. EndoQuest Robotics
    • 8.2.8.1. Company overview
    • 8.2.8.2. Financial performance
    • 8.2.8.3. Product benchmarking
    • 8.2.8.4. Strategic initiatives
  • 8.2.9. Moon Surgical
    • 8.2.9.1. Company overview
    • 8.2.9.2. Financial performance
    • 8.2.9.3. Product benchmarking
    • 8.2.9.4. Strategic initiatives
  • 8.2.10. Asensus Surgical US, Inc.
    • 8.2.10.1. Company overview
    • 8.2.10.2. Financial performance
    • 8.2.10.3. Product benchmarking
    • 8.2.10.4. Strategic initiatives
  • 8.2.11. Olympus Corporation
    • 8.2.11.1. Company overview
    • 8.2.11.2. Financial performance
    • 8.2.11.3. Product benchmarking
    • 8.2.11.4. Strategic initiatives

List of tables

• Table 1 List of secondary sources
• Table 2 List of abbreviations
• Table 3 U.S. Minimally Invasive Surgery (MIS) market, by surgical specialty, 2021 - 2033 (USD Million)
• Table 4 U.S. Minimally Invasive Surgery (MIS) market, by method, 2021 - 2033 (USD Million)
• Table 5 U.S. Minimally Invasive Surgery (MIS) market, by payer type, 2021 - 2033 (USD Million)
• Table 6 U.S. Minimally Invasive Surgery (MIS) market, by end-use, 2021 - 2033 (USD Million)

List of figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Market research approaches
• Fig. 5 Value-chain-based sizing & forecasting
• Fig. 6 QFD modeling for market share assessment
• Fig. 7 Market formulation & validation
• Fig. 8 U.S. Minimally Invasive Surgery (MIS): market outlook
• Fig. 9 U.S. Minimally Invasive Surgery (MIS) market competitive insights
• Fig. 10 Parent market outlook
• Fig. 11 Related/ancillary market outlook
• Fig. 12 Penetration and growth prospect mapping
• Fig. 13 Industry value chain analysis
• Fig. 14 U.S. Minimally Invasive Surgery (MIS) market driver impact
• Fig. 15 U.S. Minimally Invasive Surgery (MIS) market restraint impact
• Fig. 16 U.S. Minimally Invasive Surgery (MIS) market strategic initiatives analysis
• Fig. 17 U.S. Minimally Invasive Surgery (MIS) market: surgical specialty movement analysis
• Fig. 18 U.S. Minimally Invasive Surgery (MIS) market: surgical specialty outlook and key takeaways
• Fig. 19 General surgery market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 20 Gastrointestinal surgery market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 21 Gynecological surgery market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 22 Urological surgery market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 23 Cardiothoracic surgery market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 24 Orthopedic & spine surgery market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 25 Neurosurgery market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 26 Colorectal surgery market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 27 Bariatric surgery market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 28 Vascular & endovascular surgery market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 29 Plastic & reconstructive surgery market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 30 U.S. Minimally Invasive Surgery (MIS) market: method movement analysis
• Fig. 31 U.S. Minimally Invasive Surgery (MIS) market: method outlook and key takeaways
• Fig. 32 Laparoscopic surgery market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 33 Thoracoscopic surgery/VATS market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 34 Robotic-assisted surgery market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 35 Endoscopic surgery market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 36 Catheter-based interventional procedures market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 37 Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 38 U.S. Minimally Invasive Surgery (MIS) market: payer type movement analysis
• Fig. 39 U.S. Minimally Invasive Surgery (MIS) market: payer type outlook and key takeaways
• Fig. 40 Private health insurance market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 41 Medicare market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 42 Medicaid market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 43 Out-of-pocket/self-pay market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 44 Other payers market revenue estimates and forecasts, 2021 - 2033 (USD Million) - 2033 (USD Million)
• Fig. 45 Minimally Invasive Surgery (MIS) market, end use outlook key takeaways (USD Million)
• Fig. 46 Minimally Invasive Surgery (MIS) market end use movement analysis 2024 & 2033 (USD Million)
• Fig. 47 Hospitals market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 48 Ambulatory surgical centers (ASCs) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 49 Specialty clinics market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 50 Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 51 Participant categorization- U.S. Minimally Invasive Surgery (MIS) market
• Fig. 52 Market share of key market players- U.S. Minimally Invasive Surgery (MIS) market